Skip to main content
. 2015 Dec 7;10(12):e0144441. doi: 10.1371/journal.pone.0144441

Fig 1. Low expression levels of NDUFB9 in highly metastatic breast cancer cells.

Fig 1

(A) Schematic overview of iTRAQ. (B) The normalized median density of MDA-MB-231 and MDA-MB-231HM. (C) The spectrum of NDUFB9 obtained from MS. (D) The fold change ratio in the MDA-MB-231 and MDA-MB-231HM breast cancer cell lines by iTRAQ labeling based on quantitative proteomic analyses. (E,F) Protein and mRNA expression of NDUFB9 in breast cancer cell lines. Results are representative of 3 independent experiments.